CD274 and neoplasm: Therefore, we emphasize that sufficient tissue sampling should always be obtained for suspected PEAC, not only for molecular profiling but also for key biomarkers such as MSI/MMR, PD-L1, and tumor mutational burden (TMB), which inform personalized treatment decisions (28).